Free Trial
NASDAQ:AAPG

Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Ascentage Pharma Group International logo
$21.33 -0.32 (-1.48%)
As of 01:07 PM Eastern

About Ascentage Pharma Group International Stock (NASDAQ:AAPG)

Key Stats

Today's Range
$20.75
$21.86
50-Day Range
N/A
52-Week Range
$16.50
$22.43
Volume
17,318 shs
Average Volume
84,287 shs
Market Capitalization
$1.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Remove Ads
Receive AAPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter.

AAPG Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Ascentage Pharma Group Int Ltd (AAPG)
AAPG Ascentage Pharma Group International
See More Headlines

AAPG Stock Analysis - Frequently Asked Questions

Ascentage Pharma Group International's stock was trading at $18.67 at the beginning of the year. Since then, AAPG stock has increased by 14.2% and is now trading at $21.33.
View the best growth stocks for 2025 here
.

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering (IPO) on Friday, January 24th 2025. The company issued 7,325,000 shares at a price of $17.25 per share.

Ascentage Pharma Group International's quiet period expired on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During Ascentage Pharma Group International's quiet period, insiders and underwriters involved in the IPO were prevented from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AAPG
Previous Symbol
NASDAQ:AAPG
Web
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$980.65 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.86 billion
Optionable
N/A
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AAPG) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners